Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
AstraZeneca
Avacta Life Sciences Ltd
University of Nebraska
Cancer Research UK
LigaChem Biosciences, Inc.
Jonsson Comprehensive Cancer Center